Skip to content

ClearPoint Neuro CLPT Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Stryker logo
StrykerSYK
$0.100.0%
Boston Scientific logo
Boston ScientificBSX
IAR
Integra LifeSciencesIART
Medtronic logo
MedtronicMDT
Neuropace, Inc. logo
Neuropace, Inc.NPCE
ITG
Integer HoldingsITGR

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's common stock, par value (in dollars per share)?
ClearPoint Neuro (CLPT) reported common stock, par value (in dollars per share) of $0.01 in Q1 2026.
How has ClearPoint Neuro's common stock, par value (in dollars per share) changed year-over-year?
ClearPoint Neuro's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
What is the long-term trend for ClearPoint Neuro's common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), ClearPoint Neuro's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.